Zevra Therapeutics Inc (ZVRA)
9.13
+0.16
(+1.78%)
USD |
NASDAQ |
Nov 21, 16:00
9.145
+0.02
(+0.16%)
Pre-Market: 20:00
Zevra Therapeutics Max Drawdown (5Y): 99.27% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 99.27% |
September 30, 2024 | 99.27% |
August 31, 2024 | 99.27% |
July 31, 2024 | 99.27% |
June 30, 2024 | 99.27% |
May 31, 2024 | 99.27% |
April 30, 2024 | 99.27% |
March 31, 2024 | 99.27% |
February 29, 2024 | 99.27% |
January 31, 2024 | 99.27% |
December 31, 2023 | 99.27% |
November 30, 2023 | 99.27% |
October 31, 2023 | 99.27% |
September 30, 2023 | 99.27% |
August 31, 2023 | 99.27% |
July 31, 2023 | 99.27% |
June 30, 2023 | 99.27% |
May 31, 2023 | 99.27% |
April 30, 2023 | 99.27% |
March 31, 2023 | 99.27% |
February 28, 2023 | 99.27% |
January 31, 2023 | 99.27% |
December 31, 2022 | 99.27% |
November 30, 2022 | 99.27% |
October 31, 2022 | 99.27% |
Date | Value |
---|---|
September 30, 2022 | 99.27% |
August 31, 2022 | 99.27% |
July 31, 2022 | 99.27% |
June 30, 2022 | 99.27% |
May 31, 2022 | 99.27% |
April 30, 2022 | 99.27% |
March 31, 2022 | 99.27% |
February 28, 2022 | 99.27% |
January 31, 2022 | 99.27% |
December 31, 2021 | 99.27% |
November 30, 2021 | 99.27% |
October 31, 2021 | 99.27% |
September 30, 2021 | 99.27% |
August 31, 2021 | 99.27% |
July 31, 2021 | 99.27% |
June 30, 2021 | 99.27% |
May 31, 2021 | 99.27% |
April 30, 2021 | 99.27% |
March 31, 2021 | 99.27% |
February 28, 2021 | 99.27% |
January 31, 2021 | 99.27% |
December 31, 2020 | 99.27% |
November 30, 2020 | 99.27% |
October 31, 2020 | 99.27% |
September 30, 2020 | 99.27% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.18%
Minimum
Nov 2019
99.27%
Maximum
May 2020
99.23%
Average
99.27%
Median
May 2020
Max Drawdown (5Y) Benchmarks
Ionis Pharmaceuticals Inc | 70.27% |
Vanda Pharmaceuticals Inc | 89.26% |
BioCardia Inc | 98.91% |
Xeris Biopharma Holdings Inc | -- |
Instil Bio Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -28.80 |
Beta (5Y) | 1.927 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 99.32% |
Historical Sharpe Ratio (5Y) | -0.0395 |
Historical Sortino (5Y) | -0.0925 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.29% |